Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) announced that it has entered into an affiliate agreement with OnPharm-United, a 600-plus network of independent pharmacy owners throughout the Province of Ontario.
The company said all member pharmacies will have access to educational information on medical cannabis, Canntab's exclusive hard tablet medical products including cannabidiol (CBD) and tetrahydrocannabinol (THC) and all necessary tools to permit the pharmacists to refer patients to the Canntab.ca website to fulfill their prescriptions for medical cannabis.
“This important relationship, with a large network of highly respected pharmacists, is a testament and recognition of the importance of the health benefits of medical cannabis as well as Canntab's key role in delivering true pharmaceutical grade THC and CBD to those medical patients in a trusted and precise dosage format,” Canntab Therapeutics CEO Larry Latowsky said in a statement.
READ: Canntab Therapeutics announces historic agreement with First Nations Grower to address opioid crisis among Indigenous Peoples
“As an example, many pharmacies are either in proximity or often affiliated with pain clinics and therefore providing both the pharmacist and patient with ease of access to the necessary information required to access medical cannabis and the Canntab solid oral dose offerings,” Latowsky added.
Canntab noted the agreement is just one of many other affiliate deals which Canntab hopes to enter into with other pharmacy networks.
As well, the company reported that it has received approval from the Province of Saskatchewan to sell the entire portfolio of Canntab solid oral dose products to the province’s wholesale and provincial stores effective immediately.
Canntab Therapeutics is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations.
The firm's proprietary hard pill cannabinoid formulations provide doctors, patients and consumers with medical-grade solutions which incorporate all the features one would expect from any prescription or over the counter medication sold in Canadian pharmacies.
Contact Sean at sean@proactiveinvestors.com